Alzeca Biosciences

Focus: Alzeca Biosciences is a Houston-based biotech company focused on developing imaging compounds for Alzheimer's disease detection and diagnosis. The company operates as a pre-revenue stage biotech with a highly specialized therapeutic focus.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Alzeca Biosciences

AI assessmentNot Hiring

No open roles listed right now. Follow Alzeca Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

DSPE-DOTA-Gd liposomal injection

Alzheimer Disease

Phase 1

Clinical Trials (1)

NCT05453539Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease

Phase 1

Help build intelligence for Alzeca Biosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity in high-need neurology space where Alzheimer's imaging biomarkers are critical for drug development and clinical diagnosis
Specialized focus on imaging compounds positions you at the intersection of diagnostics and therapeutic development, a growing career track
Potential for significant individual impact in a small, focused team working on foundational Alzheimer's technology

Watch Out For

Pre-revenue stage with no public financial data, funding information, or employee count disclosed—indicates early-stage cash and runway risks
Only one Phase 1 program active with zero Phase 2 or Phase 3 assets; minimal near-term revenue catalysts or clinical validation milestones
Currently zero open job postings and no hiring by department data visible, suggesting minimal expansion or team-building activity

Generated by Claude from Alzeca Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 1 clinical trial

Top TAs: Neurology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Neurology

1 pipeline

Marketed

Pipeline